Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History IVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics IVA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – EUR
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Inventiva S.A

IVA
Current price
3.40 USD +0.15 USD (+4.62%)
Last closed 2.78 EUR
ISIN FR0013233012
Sector Healthcare
Industry Biotechnology
Exchange PA
Capitalization 396 074 430 EUR
Yield for 12 month -6.68 %
1Y
3Y
5Y
10Y
15Y
IVA
21.11.2021 - 28.11.2021

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France. Address: 50 rue de Dijon, Daix, France, 21121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.43 EUR

P/E ratio

Dividend Yield

Financials IVA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures IVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+14 586 599 EUR

Last Year

+17 313 909 EUR

Current Quarter

+11 878 112 EUR

Last Quarter

+2 708 487 EUR

Current Year

+9 112 167 EUR

Last Year

+17 336 694 EUR

Current Quarter

+11 357 021 EUR

Last Quarter

+2 708 487 EUR
EBITDA -92 887 037 EUR
Operating Margin TTM -384.43 %
Price to Earnings
Return On Assets TTM -63.60 %
PEG Ratio
Return On Equity TTM -1 642.76 %
Wall Street Target Price 5.43 EUR
Revenue TTM 13 962 478 EUR
Book Value -1.10 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -29.90 %
Dividend Yield
Gross Profit TTM 12 578 515 EUR
Earnings per share -3.05 EUR
Diluted Eps TTM -3.05 EUR
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation IVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 38.50
Price Sales TTM 28.37
Enterprise Value EBITDA -2.31
Price Book MRQ 2.00

Technical indicators IVA

For 52 weeks

1.42 EUR 3.27 EUR
50 Day MA 2.94 EUR
Shares Short Prior Month
200 Day MA 2.46 EUR
Short Ratio
Shares Short
Short Percent